|
Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study. |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer; Roche; Sanofi; Tesaro |
Research Funding - Astellas Pharma; Janssen |
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Roche; tesaro |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Tesaro |
|
Sophie Abadie Lacourtoisie |
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; Pierre Fabre |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Pierre Fabre |
|
|
Consulting or Advisory Role - AstraZeneca; CLOVIS ONCOLOGY; GlaxoSmithKline; MSD Oncology; Roche; Tesaro |
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Roche; Tesaro |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; NanoString Technologies; Roche |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; ECS PROGASTRIN; GlaxoSmithKline; LEK; Novartis; Roche/Genentech; TESARO |
Research Funding - Merck Serono (Inst); Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech |
|
|
No Relationships to Disclose |
|
Anne-Claire Hardy-Bessard |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Novartis; LEO Pharma; Sanofi; Tesaro |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Expert Testimony - AstraZeneca; Ipsen; Novartis; Tesaro |
Travel, Accommodations, Expenses - AstraZeneca; tesaro |
|
|
Honoraria - AstraZeneca; GlaxoSmithKline; Ipsen; MSD Oncology; MSD Oncology; Novartis; Roche/Genentech; Sanofi/Aventis |
Consulting or Advisory Role - AstraZeneca; Ipsen; Novartis; Roche; Sanofi |
Research Funding - Janssen (Inst); MSD Oncology (Inst) |
Travel, Accommodations, Expenses - Janssen; Novartis |